Plans For Off Road Buggy Free

Hunters
bodies in India



Posted by Miguel Jara on April 30, 2010 Source

No had finished reading me the excellent book by Sonia Shah, bodies Hunters (451 Publishers, 2009) when it happens the death of four girls and the serious adverse effects over a hundred

put on the vaccine after the virus Human papillomavirus (HPV)

. Because it is what it is, a hunt for bodies to Alimet business clinical trials and drug products. Narrates this investigative journalist whose book has a foreword the same John Le Carre, author of The Constant Gardener on him the same topic) that the Neeman Medical International

announce their ability to "access to large patient populations that have not yet been exploitation "of Latin America and Asia.

has this degree in Journalism, Philosophy and Neuroscience used to denounce the corporate power, trade shows and conferences to support this recent trend to mass trials in poor countries and the press
sector offers "encouraging news" with titles such as:

"India, an opportunity to conduct clinical trials valued at one billion dollars."

poor countries have become a huge Planetary Laboratory. The drugs we consume in the West are increasingly tested in the poor and helpless in these countries. This is what has happened in India, Merck and GlaxoSmithKline, marketers of the HPV vaccine advantage several factors that make interesting experience their preparation. In these countries there are a lot of people in poverty selling their bodies to "science" with little money. The cultural factor is crucial, is experienced with the poor because in addition to that cost less are not capable enough information to assess what is provided. Parents of these children who died were mostly illiterate . On the other hand, the governments of these COUNTRIES, are delighted to welcome the big corporations they represent human experimentation "

investments, bring money. And do not forget that the laws on health

and in particular clinical trials are

lax compared with those of our countries, much more stringent, at least on paper. And I write this because what good is this regulation of the marketing process of a medical device then if he causes serious damage to the health of girls, as has happened in Spain not only to the cases of Valencia, the government is doing nothing? At least in India are investigating. What a paradox.

Merck is one of the laboratories have expected by now most of its production of human trials in poor countries, according to the book

Hunters

bodies.

Keep in mind that this product was very challenged by

health professionals have even asked

since the start of vaccination a moratorium on it.

HPV infection is necessary but not sufficient for acquiring cervical cancer and also in 90% of cases, the infection spontaneously remits . Mortality from this cancer is low compared to the more common and occurs in around 60 years old in people who used to be reviews (which must still be possible even though they have since the vaccine.) Its effectiveness has not been studied in children, only adults. Does not protect against all cancer-causing strains of HPV, is preventive

but not cure. His price is very expensive, over $ 300 three-dose in some communities -. 500 And about safety little is known. Urge

that the English Government provide answers to parents of girls affected by this vaccine. Health must review the inclusion of the vaccine in the vaccine calendiario English. Drug agencies have to intervene and study these cases. Urge create more ethics committees at these rehearsals and before starting with a strong scientific justification, not only commercial , as now they are many (compare a drug with an existing one to find any difference with which to create added value and justify their sale or a marketing campaign based on these results, even when it is discovered that the drug proved no better than the existing one). More info: The book next health. New diseases and the marketing of fear

(Peninsula, 2009) is devoted to how to make campaigns marketing fear as the vaccine against human papilloma virus.